Tessellate BIO discovers and develops novel precision oncology medicines with the mission to turn cancer patients into cancer survivors.
A private preclinical stage biotechnology company, Tessellate BIO is redefining Synthetic Lethality by developing drugs that target unexplored or difficult to drug pathways beyond HRD.
Headquartered in the Netherlands and with research labs at the Stevenage Bioscience Catalyst, UK, Tessellate BIO is supported by top-tier life science investors BioGeneration Ventures (BGV) and Forbion.
Company Details
- Employees
- 30
- Address
- Gooimeer 2, Amsterdam,1411 Dc,netherlands
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://tessellatebio.com/
- HQ
- Amsterdam
Tessellate Bio Questions
Tessellate Bio's website is http://tessellatebio.com/
Tessellate Bio's LinkedIn profile is https://nl.linkedin.com/company/tessellatebio
Tessellate Bio has
30 employees.
View email and phone details for 30
employees at Tessellate Bio.
Tessellate Bio's industry is
Biotechnology Research
Tessellate Bio's top competitors are
Apexomic,
Boehringer Ingelheim,
Antikor Biopharma Ltd,
F-Star Therapeutics,
Ambrose Healthcare,
Stevenage Bioscience Catalyst,
Bgv (Biogeneration Ventures),
Ignota Labs,
Camgene Therapeutics,
Levicept Ltd.
Tessellate Bio's categories are Biotechnology Research
